Novozymes A/S (OTCMKTS:NVZMY) Sees Significant Growth in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 26,584 shares, an increase of 87.2% from the June 30th total of 14,203 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 76,138 shares, the days-to-cover ratio is presently 0.3 days.

Novozymes A/S Stock Performance

Shares of NVZMY stock opened at $63.95 on Thursday. The company has a current ratio of 1.67, a quick ratio of 1.03 and a debt-to-equity ratio of 0.27. Novozymes A/S has a 12-month low of $49.90 and a 12-month high of $66.82. The business’s 50 day moving average is $61.45 and its two-hundred day moving average is $60.45. The company has a market capitalization of $26.51 billion, a P/E ratio of 43.21, a P/E/G ratio of 3.01 and a beta of 0.92.

Novozymes A/S (OTCMKTS:NVZMY) last announced its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%. The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Analysts expect that Novozymes A/S will post 2.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on NVZMY shares. Kepler Capital Markets upgraded shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Zacks Research raised Novozymes A/S from a “strong sell” rating to a “hold” rating in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy”.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).